Loading clinical trials...
Loading clinical trials...
Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD
Conditions
Interventions
Stiolto Respimat
ICS (Inhaled Corticosteroid) (Triple therapy)
+2 more
Locations
90
United States
Pulmonary Associates of Mobile, PC
Mobile, Alabama, United States
Healthscan Clinical Trials LLC
Montgomery, Alabama, United States
HealthScan Research
Montgomery, Alabama, United States
Diamond Childrens Medical Center
Tucson, Arizona, United States
CareMore Apple Valley Care Center
Apple Valley, California, United States
HealthCare Partners
Commerce, California, United States
Start Date
September 20, 2017
Primary Completion Date
September 30, 2020
Completion Date
September 30, 2020
Last Updated
June 14, 2022
NCT06712563
NCT07518472
NCT06831994
NCT02755974
NCT07363980
NCT03044847
Lead Sponsor
Boehringer Ingelheim
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions